Nalaganje...
Chitosan oligosaccharide (GO2KA1) improves postprandial glycemic response in subjects with impaired glucose tolerance and impaired fasting glucose and in healthy subjects: a crossover, randomized controlled trial
BACKGROUND: The antidiabetic and hypoglycemic effects of chitosan have been reported in previous studies. We have previously shown that chitosan oligosaccharide reduces postprandial blood glucose levels in vivo. We conducted a short-term crossover study to support the results of the previous study....
Shranjeno v:
| izdano v: | Nutr Diabetes |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group UK
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6828684/ https://ncbi.nlm.nih.gov/pubmed/31685797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41387-019-0099-4 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|